Full List Of Stories
17 Jan
BoA stays 'neutral' on Unilever, says upside and downside risks 'well balanced'
Analysts at Bank of America reiterated their 'neutral' recommendation for shares of Unilever following news at the weekend that it had made three bids for GlaxoSmithKline's consumer health business, telling clients they belived that upside and downside risks to the share price were "well balanced" at current levels.